Mr. Maulik Patel, CMD, Epigral, interview with ICN on FY2024 performance and growth prospects

Epigral Q4 FY24 QoQ PAT up 55% at Rs. 77 Cr

Epigral jumps after Q4 PAT rises 57% QoQ to Rs 77 cr

Epigral Ltd recommends final dividend of Rs. 5

Epigral Ltd Q4 FY24 consolidated PAT jumps QoQ to Rs. 77.27 crores

Epigral expands its CPVC resin capacity to 75,000 TPA

Epigral commissioned and expanded its CPVC resin capacity by 1.5 times to 75,000 TPA

Epigral commissions 45,000 TPA capacity of CPVC resin plant at Dahej

In an interaction with Maulik Patel, CMD, Epigral Ltd

Epigral’s in-house R&D unit receives recognition from India’s Ministry of Science & Technology

Epigral Ltd Q3 FY24 consolidated PAT up QoQ at Rs. 49.08 crores

Epigral Q3 FY24 consolidated PAT up QoQ at Rs. 49.08 Cr

Epigral opens Rs. 30 crore R&D Centre in Ahmedabad

Epigral Limited opens its first R&D Centre in Ahmedabad

Chemicals producer Epigral sets up first R&D centre in Gujarat

Epigral posts Q2 FY24 consolidated PAT at Rs. 38 Cr

Indian chemicals maker Epigral expects revenue from newer products to surge this year

‘Meghmani Finechem Limited’ is now ‘Epigral Limited’